Provider review
Tryozi review
Same price at any dose — the disclosure is excellent, the structure is not.
A quarter dose is billed like a full one, stated plainly. The advertised figure covers four weeks and then doubles. The prepay discounts are published as percentages, so the cheapest rung is a number you have to derive.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Tryozi
$279/mo semaglutide standing, flat at every dose
- Vs median
- $110/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Same price at every dose
- Dispensed
- Compounded by RedRock · Health Warehouse · Precision Medicine · Triad Rx
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Take a quarter dose here and you pay the full-dose rate — Tryozi says so in the reader's own words, on the same page as everything else. And that page is genuinely better than most: the intro price, its four-week limit, the standing rate and the prepay ladder all sit together, the FDA question is answered with a flat no rather than a hedge, and all four compounding pharmacies are named with an explicit invitation to go and check them. That last part is rare enough to be worth switching for, if the structure suited you. It does not suit someone taking less. Two things will cost you if you misread them. The advertised figure buys four weeks and then doubles. And the prepay discounts are published as percentages off the monthly rate rather than as prices, so the cheapest rung is a number you have to work out rather than one you can read.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You expect to titrate upward and want a monthly figure that does not follow the dose
- You want to know which pharmacies prepare your medication, and to be able to check them
- You want the intro price, its expiry and the standing rate in one sentence rather than in a footnote
Look elsewhere if
- You are taking less to spend less — the smaller dose is billed like the full one
- You are budgeting from the advertised figure. It buys four weeks, then doubles
- You want to compare prepay rungs across providers — these are published as percentages, not prices
- You need to know how high a dose the flat rate covers. No milligram range is published
What it actually costs
Price as published
Compounded semaglutide $279/month and compounded tirzepatide $379/month standing, one price at every dose — "Your monthly price doesn't jump as your dose increases" · the intro is bounded in the same sentence as the price: "$139 for your first 4 weeks, then $279/mo" and "$189 for your first 4 weeks, then $379/mo" · prepay rungs are published as discounts off the monthly rate rather than as figures — 12 weeks −22%, 24 weeks −29%, 52 weeks −47% · brand comparators priced on the same page: Ozempic $1,299 and Zepbound $1,399, both billed monthly · no milligram range is published against the flat rate
- Vs median
- $110/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Same price at every dose
One figure regardless of how much drug you take. Reassuring if you expect to titrate upward, and the least economical structure on this page if you do not: a quarter dose costs what a full one does.
88 of the 373 programs we track price a small dose this way. One figure at every dose, stated in the reader's own words on the same page as the intro price and the prepay ladder. Taking less returns nothing; the only lever is committing for longer, and those rungs are published as percentages rather than as prices.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Flat at every dose
- Price last updated
- August 2026
What it does well
- Names all four of its 503A compounding pharmacies — RedRock, Health Warehouse, Precision Medicine and Triad Rx — and tells the reader to go and verify them
- Prints the intro price and the standing price in one sentence, with the intro's length in weeks: "$139 for your first 4 weeks, then $279/mo"
- States the flat-dose rule in the reader's own words: "Your monthly price doesn't jump as your dose increases"
- Answers the FDA question without hedging: "Is this medication reviewed by the FDA? No. Compounded medications are prepared by licensed 503A U.S. pharmacies to your prescription and are not FDA-approved"
- Publishes the whole prepay ladder as a visible set of options rather than surfacing only the cheapest rung
- Carries a LegitScript seal number (51202394) and a named operating entity with an address
Pharmacy, labs and oversight
Tryozi dispenses through a RedRock · Health Warehouse · Precision Medicine · Triad Rx facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
4 of 4 published openly
What Tryozi publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsOne price at every dose, so the bill is knowable before you titrate.
- Published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Tryozi sells compounded semaglutide and compounded tirzepatide as weekly injections in all 50 states and Washington DC, with the flat-dose rule, the introductory price, the standing rate and the prepay ladder all on one page. It names all four of its 503A compounding pharmacies and invites the reader to check them: "Our 503A pharmacy partners are listed by name, RedRock, Health Warehouse, Precision Medicine, Triad Rx, so you can verify who prepares your medication for yourself." It displays a LegitScript seal number, answers the FDA question without hedging, and is registered as Tryozi Group LLC in Pembroke Pines, Florida.
The honest cons
ONE PRICE AT EVERY DOSE. A patient deliberately holding a quarter dose pays the same $279 as one at the top of the range
- THE ADVERTISED $139 BUYS FOUR WEEKS. The standing rate is $279, twice as much, and the intro is bounded in weeks while the standing rate is quoted per month
- The prepay rungs are published only as percentages — 22%, 29% and 47% off — so the actual figures are printed nowhere
- No milligram range is published against the flat price, so the upper bound of what "any dose" covers is unstated
- Which of the four named pharmacies fills a given order, and on what basis, is not published
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Tryozi is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#114 of 373
Ordered with the companies that pay us first, and Tryozi is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- Low dose vs full dose
- What a flat price costs at a low dose
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
MadeMed
$239/mo flat
- Vs median
- $70/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Same price at every dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the MadeMed review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.